COVID-19
-
COVID-19 vaccination underway in Oxfordshire
Tuesday 8 December 2020 was a momentous day for Oxfordshire as the highly anticipated COVID-19 vaccination programme started at the Churchill Hospital.
-
Oxfordshire to be in ‘Tier-2: High Alert’ post 02 December lockdown
Just about all you need to know about post lockdown in Oxford and across Oxfordshire on 02 December, from the PM’s announcement regarding the end of the second national lockdown to any significant developments.
-
Oxford Vaccine up to 90% effective and to be sold at cost to developing nations
The University of Oxford and AstraZeneca vaccine ChAdOx1 nCoV-2019 is up to 90% effective at preventing COVID-19 and will be sold at cost to developing nations in perpetuity.
-
Oxford Uni’s vaccine research and development boosted by £3.3m gift from Wafic Saïd
The University of Oxford has secured a critical professorship in vaccinology for the future following a gift of £3.33 million from the Saïd family.
-
UK’s first vaccines manufacturing and innovation centre set to open in Oxfordshire in 2021
The Vaccines Manufacturing and Innovation Centre (VMIC) is the first of its kind in Europe and will provide vaccine development and advanced manufacturing capability.
-
Oxford-developed Rapid COVID-19 test now in use at Heathrow Airport
A rapid COVID-19 test developed at Oxford University is now being used at Heathrow and being trialled at Hong Kong International Airport to screen passengers.
-
City Council ready to support city through second lockdown
Oxford City Council is activating its contingency plans to support residents and businesses through a new lockdown that begins on Thursday.
-
Oxford City to go into local COVID alert level Tier 2 – High Alert
With effect from 00.01 on Saturday 31 October, Oxford City will be placed in Tier 2 – High Alert for coronavirus, following a recent rise in the number of cases in the city.
-
Oxford scientists develop extremely rapid diagnostic test for COVID-19
Scientists from Oxford University’s Department of Physics have developed an extremely rapid diagnostic test that detects and identifies viruses in less than five minutes.
-
Oxford Nanopore raises £84.4M in new capital
Oxford Nanopore Technologies has raised £84.4M in new capital from existing investors and new investors, including International Holdings Company (IHC) and RPMI Railpen.
-
Oxford University reports 61 COVID-19 cases in Freshers’ Week
Oxford University’s testing service has confirmed 61 positive tests for COVID-19 in Freshers’ Week bringing the total number to 91 since 30 August.
-
Oxford University launches vaccination role-play computer game
Oxford University has launched a free game that allows players role-play virtual vaccination to halt the global spread of a viral pandemic.
-
Antigen company launches antibodies to further fight against COVID-19
The Native Antigen Company has announced the introduction of 10 new monoclonal antibodies recognising SARS-CoV-2, the causative agent of COVID-19.
-
Oxford prepares for the safe return of university students
Oxford prepares for the safe return of university students with a range of measures to help keep students, staff and residents safe.
-
Oxford Nanopore partners with UK Gov on new generation COVID-19 test
The test is fully scalable and designed to enable both high-volume screening and rapid, local testing, and results can be obtained in under two hours.
-
Oxford University backs local charities in COVID-19 community response
Oxford University backs local charities’ community support package in response to COVID-19 and works with local authorities providing assistance locally.